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The mammalian IlF3 and NF90 proteins, involved in several cellular functions, have common N-terminal and central sequences and specific C-
terminal regions. These proteins exhibit a large heterogeneity generated by posttranscriptional and posttranslational modifications. Part of their
polymorphism is due to the alternative splicing of exon 3 located just downstream of the translation initiation codon. This 39-nucleotide-long
exon, not described so far, codes for an N-terminal sequence of 13 residues (ALYHHHFITRRRR) also present in rat and human IlF3 or NF90.
Four mRNAs are expressed in mouse brain, two for Ilf3 and two for NF90, differing in their 3′ sequence to generate the specific Ilf3 and NF90 C-
terminal domains and in the presence or the absence of exon 3 to generate long and short isoforms of both proteins. By RT-PCR, no other variants
were found. Combining our results and GenBank sequences, we determined the exon–intron organization of the entire mouse Ilf3 gene divided
into 22 exons.
© 2006 Elsevier Inc. All rights reserved.Keywords: Alternative splicing; Gene map; Heterogeneity; Ilf 3; NF90; Protein expressionProtein heterogeneity is a key mechanism for diversifying
and/or regulating the subcellular localization and cellular
functions of polypeptides. Polymorphism is generated mainly
by two independent mechanisms, alternative splicing [1] and
posttranslational modifications.
We previously characterized two related proteins, inter-
leukin enhancer binding factor 3 (Ilf3) and nuclear factor 90
(NF90), that bind to the nucleotide (nt) axonal targeting
element of Tau mRNA and escort it from the nucleus to the
axon hillock [2]. These two proteins derive from a single gene
(approved gene symbol Ilf3) by alternative splicing that
provides each protein with a long and identical N-terminal
domain and a specific C-terminal domain [3,4]. Analyzed by
resolving 2-D PAGE, we observed that both Ilf3 and NF90
display a substantial heterogeneity [2]. Indeed, Ilf3 and NF90
can be resolved into at least 12 and 8 spots, respectively,☆ Sequence data from this article have been deposited with the GenBank Data
Library under Accession Nos. AF497751, AF497752, DQ104405, and
DQ104406.
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doi:10.1016/j.ygeno.2006.08.006differing in their apparent molecular weight and their pI. This
protein polymorphism suggests that Ilf3 and NF90 may
undergo posttranscriptional and/or posttranslational modifica-
tions. In addition to the alternative splicing that produces the
different C-terminal regions, two posttranslational modifica-
tions of Ilf3 and NF90 have been reported: arginine methylation
by protein-arginine methyltransferase I in the RGG motif [5]
and phosphorylation by the double-stranded RNA-dependent
protein kinase PKR [4,6,7].
The presence of several Ilf3 and NF90 isoforms, generated
by a combination of modifications, could explain the various
cellular functions described for these two proteins: transcrip-
tional activation [8–10], eukaryotic and viral RNA binding
[2,11–15], translational inhibition [16–18], or enzymatic
regulation [5,6]. Moreover, the variation in the isoform
composition of Ilf3 and NF90 may be related to their
subcellular localization [19]. Both proteins, found in nuclear
and cytoplasmic fractions [2], may feed a shuttle between these
two compartments [20]. Finally, the regulation of the interac-
tions of Ilf3 and NF90 with their protein or RNA partners could
be actively modulated by their posttranscriptional and/or
posttranslational modifications [10,19].
623W. Viranaicken et al. / Genomics 88 (2006) 622–632To understand the origin of Ilf3 and NF90 polymorphism,
we investigated first the existence of additional splicing events
that could contribute to generating the different protein species.
Work concerning Ilf3/NF90 posttranslational modifications will
be reported elsewhere (W. Viranaicken et al., manuscript in
preparation).Table 1
Sequence and localization of oligodeoxynucleotides in the Ilf3/NF90 sequences
Oligonucleotide Numbering in the corresponding sequence Seq
IN-5-1 22–45 5′-
IN-5-2 94–122 5′-
IN-5-3 157–174 5′-
IN-5-4 a 202–243 5′-
TT
IN-5-5a 217–263 5′-
IN-5-6a 202–204/243–263 5′-
IN-5-7 446–466 5′-
IN-5-8 1346–1375 5′-
IN-5-9 1593–1621 5′-
IN-5-10 1744–1769 5′-
IN-3-1 2135–2106 5′-
IN-3-2 1846–1821 5′-
IN-3-3 1080–1051 5′-
IN-3-4 949–929 5′-
IN-3-5 537–509 5′-
IN-3-6 512–495 5′-
IN-3-7 294–274 5′-
I-5-1 2872–2901 5′-
I-3-1 2352–2323 5′-
N-5-1 2305–2344 5′-
N-3-1 2383–2354 5′-
N-3-2a 2352–2305 5′-
AG
N-3-3 2304–2269 (Ilf3) b 5′-
TA2334–2269 (NF90)
76α-3c 32223–32194 (gene) 5′-
76δ-3c 33163–33134 (gene) 5′-
(AGC)dT d − 5′-
Oligodeoxynucleotide sequences used for RT or PCR experiments are given with
sequence.
a Italic characters correspond to noncomplementary sequences used to introduce
GCGGCCGC, NotI) and/or missing sequence of the novel exon 3.
b Partial (italic characters) or total hybridization of oligodeoxynucleotide N-3-3 w
c 3′ oligodeoxynucleotides complementary to the Ilf 3 genomic sequence and used
previously described [3].
d 3′ anchoring oligodeoxynucleotide complementary to the 5′ region of the polyIn this work, we searched in mouse brain for the additional
splicing events previously reported in human melanoma cells
SK-MEL-28 [3] and occurring at the 3′ end of NF90 and for
those deduced from mouse EST data bank sequences. These
latter events correspond to the presence of a longer exon 3 or to
the alternative splicing of exon 4 and/or exon 6. None of theseuence of the oligonucleotide
GACTTGTACAGCCATGCAGGAAGG-3′
CTGTACCACTTAGATAGTTGAAGTATTGG-3′
GATAAGCCAAGACTGATTTCC-3′
ATAAGAATGCGGCCGCATATGGCATTGTATCATCATCAC
CATCACAAGAAGAAGAAGG-3′
CATCACTTCATCACAAGAAGAAGAAGGCGTCCCATGAGAATTTTTGTG-3′
ATAAGAATGCGGCCGCATATGCGTCCCATGAGAATTTTTGTG-3′
AGACGATGAGAGCAAAGAAGG-3′
CCATGAAACGCCCTATGGAAGAGGATGGGG-3′
GACTGCCAAGCTTCATGTAGCTGTGAAGG-3′
GTCTCCAACCCCAGTTCTGTCTTCCC-3′
GCCTCCACCACCGGCATTCCCAGAATGCCC-3′
TCTTCTCATTAAGCTCCATAACAGGG-3′
TGCCAGGCACTCCAGCACTCTCCGGAGGGC-3′
CACAAGTCCCTTAGGACACGG-3′
GGCTACCAGGCCGACCCGCATCACGCCCC-3′
5′-GCATCATCCACAGACTGG-3′-3′
ATGCTTTGCCATCACGTGGCG-3′
TACCAGTCCTCACAGGGTGGCTACAGTCGG-3′
GCCTCCACCACCGGCATTCCCAGAATGCCC-3′
GACTTTTTCACAGACTGCTACGGCTATCATGATTTTGGGG-3′
AGTTGATTTTGTGTCAATACTTTTAGACGC-3′
CGCGGATCCGCCTAGGAAGCCCCAAAATCATGATAGCCGT
CAGTCTGTGAAAAAGTC-3′
ATGATAGCCGTAGCAGTCTGTGAAAAAGTCACTG
GCCTGCTGTGGCCGAATTGCTGCTGTACCC-3′
TGAGGCCAGCACCCTACCCTAATGAGACCC-3′
GCTCAGTAAAAAGGCAAGGAAAGAGTCAGC-3′
TTTTTTTTTTTTTTT(AGC)-3′
their localization within the Ilf3 mRNA [11], NF90 mRNA, or Ilf3 genomic
into the cDNA specific restriction sites (GGATCC, BamHI; CATATG, NdeI;
ith mouse Ilf 3 or NF90 mRNA.
in RT-PCR experiments to search for the presence of DRBP76α and DRBP76δ
(A) tail.
624 W. Viranaicken et al. / Genomics 88 (2006) 622–632alternative transcripts was found to occur in mouse brain but
we identified a new, yet undescribed exon at the 5′ end of the
Ilf3 gene with canonical splice junction sites, located in the
middle of intron 2 in the human or mouse gene sequences
([3,4]; GenBank Accession No. AF506968). This 39-nt
sequence corresponding to the new exon 3 can be alternatively
spliced, thus generating Ilf3 and NF90 isoforms containing or
not an attachable N-terminal sequence of 13 residues (aa 2–
14). Taking into account the existence of this exon 3 and
additional sequence data of exon 1, we propose a novel mouse
Ilf3 gene map. Finally, analysis of the expression levels of Ilf3
and NF90 showed that Ilf3 is two- to threefold more abundant
than NF90 but no evidence for the control of the isoform ratio
was found.
The N-terminal location of the extra 13-aa segment, its
alternative presence, and its particular amino acid composition,
enriched in basic residues, could confer to this signal-type motif
specific properties to regulate the intracellular localization, the
binding properties, or the cellular functions of Ilf3/NF90.Fig. 1. RT-PCR analysis of the alternative splicing in the 5′ region common to Ilf 3 an
for nested PCR. The primers used for the two successive PCR are indicated with the s
and IN-3-7 primers). Black boxes, 5′ and 3′ UTR regions; open boxes, coding region
the resulting predicted amino acid sequences of the two isoforms are indicated belo
cDNA probe or with oligodeoxynucleotide probes corresponding to nucleotides 243
agarose gel of nested PCR products (control, C) or heat-denatured and slowly renatuResults
Characterization of a novel 5′ alternative splicing that
generates long and short isoforms of Ilf3 and NF90
When various EST and cDNAs were used to assemble full-
length Ilf3 and NF90 constructs, two distinct sequences were
found in the 5′ domain, differing by the presence of 39 nt
positioned just after the AUG codon. To verify the existence of
the two corresponding mRNAs in mouse brain, we carried out
RT-PCR experiments using nested primers (see Table 1). Using
15-day embryonic or adult mouse brain RNA as templates and
specific primers (thick/thin arrows in Fig. 1A), three distinct
bands were amplified (Fig. 1B, ethidium bromide). All three
bandshybridized toacommon3′cDNAprobeand to the243–264
probe (downstreamof the extra 39-nt segment) (Fig. 1B).Using a
probe corresponding to the first 20 nt of the 39-nt segment, only
the twoupperbandsweredetected (Fig. 1B).As these resultswere
compatible with the existence of two splicing events, the threed NF90 mRNA. (A) Localization in the mouse Ilf 3 transcript of the primers used
ame size arrows (large arrows, IN-5-1 and IN-3-5 primers; small arrows, IN-5-2
s; shaded area, putative alternative spliced region. The nucleotide sequence and
w. (B) Southern blot analysis of nested PCR products done either with the Ilf 3
–264 or 202–222. Molecular weights are in kb. (C) Separation in 1.5% (w/v)
red (HT) products, stained with ethidium bromide. Molecular weights are in bp.
625W. Viranaicken et al. / Genomics 88 (2006) 622–632amplified fragments were cloned and sequenced. The 39-nt
sequence was found only in the two upper bands. As identical
sequenceswere obtainedwith the twoupper bands,we concluded
that only one alternative splicing event occurs in this 5′ region,
generating one long (L) and one short (S) isoform, depending on
the presence of the extra 39-nt segment in the mRNA.
The presence of three bands for only two sequences could be
explained by the formation of heteroduplexes between L and S
versions of polynucleotides during the last annealing phase of
the second PCR experiment (from 95 to 55°C within 1 min). To
verify this hypothesis, RT-PCR experiments were carried out as
previously (Fig. 1B) except that after 30 cycles, incubation
mixtures were left 10 min at 95°C and then allowed to cool
down to 55°C for 120 min (1°C drop every 3 min). These
conditions favor the reannealing of homoduplexes and
prevented heteroduplex formation [21]. As shown in Fig. 1C,
only two bands were effectively obtained. We concluded that
the upper band that had disappeared from the gels under these
conditions corresponded to L/S heteroduplexes whose migra-
tion during gel electrophoresis was slowed down because of the
presence of a deletion loop. The use of specific Ilf3 or NF90
primers for PCR experiments combined with analysis of se-
quences available in the EST data bank confirmed the
presence of this novel exon in Ilf3 and NF90 mRNAs (data
not shown).
Altogether, these results demonstrate the presence of distinct
mRNAs for Ilf3/NF90 in mouse brain, differing by the
alternative presence of a 39-nt sequence that specifies a 13-aa
segment at the N-terminus (aa 2–14) of the proteins. TheseFig. 2. RT-PCR analysis of the alternative splicing of exon 4 and/or 6 common to Ilf 3
used for the nested PCR and sizes of the expected PCR fragments according to the p
correspond to the amplification carried out with IN-5-7 and IN-3-4 primers or with IN
gel of amplified fragments obtained in PCR. (Right) Higher magnification of gel. Mresults reveal the existence of a novel exon in the Ilf3 gene. The
alternative N-terminus could explain at least in part the
heterogeneity of Ilf3 and NF90 observed in the molecular
weight dimension of 2-D gels [2] and in 1-D SDS–PAGE as well.
The search for exon 3 containing 15 additional nucleotides in its
5′ region and for alternative splicing of exon 4 and/or exon 6
Several mouse Ilf3/NF90 EST available in data banks
contain a longer exon 3 with an additional 15 nt in its 5′ region
(in 7 of 167 ESTexamined). This longer exon 3 could have been
generated using another splicing acceptor site in the 3′ end of
intron 2. In RT-PCR experiments presented in Fig. 1, primers
IN-5-2 and IN-3-7, which surround the concerned region, were
used. No band corresponding to an amplified fragment
lengthened by 15 nt was observed. Moreover, with additional
RT-PCR experiments using other primers (IN-5-3 and IN-3-7)
to amplify smaller fragments and enhance the resolution of their
separation in agarose gels, we never observed the expected
fragments (data not shown).
On the other hand, several transcripts devoid of exon 4 and/
or exon 6 are also present in mouse EST data banks. Analysis
of the available 230 EST containing this region, common to
Ilf3 and NF90 mRNA, revealed 5 EST without exon 4, 2 EST
without exon 6, and only 1 lacking both exons. To test whether
these events occurred in mouse brain, RT-PCR experiments
were carried out using primers IN-5-7 and IN-3-4, correspon-
ding to the 3′ end of exon 3 and to the 5′ end of exon 7,
respectively (Fig. 2). Given the sizes of exons 4, 5, and 6 (178,and NF90 mRNA. (Top) Localization in the mouse Ilf 3 transcript of the primers
utative alternative splicing of exon 4 and/or exon 6. Roman and italic characters
-5-7 and IN-3-6 primers, respectively. (Bottom) Separation in 2% (w/v) agarose
olecular weights are in bp.
Fig. 3. RT-PCR analysis of the alternative splicing in the 3′ region specific to Ilf 3 and NF90 mRNA. (Top) Localization in the mouse Ilf 3, NF90, and DRBP76
transcripts of the primers used for the RT-PCR (left) and sizes of the expected PCR fragments with reference to the human known transcripts (right). (Bottom)
Separation in 1.0% (w/v) agarose gel of fragments obtained in PCR. Molecular weights are in bp.
626 W. Viranaicken et al. / Genomics 88 (2006) 622–632148, and 92 bp, respectively), unspliced mRNAwould give rise
to amplified fragments of 504 bp. In the case of mouse brain
Ilf3/NF90 mRNA lacking exon 4 or 6 or both, the expected
lengths of the amplified fragments would be of 326, 412, or
234 bp, respectively (top of Fig. 2). The only amplified
fragment detected in our experiments corresponded to 504 bp
(Fig. 2, bottom), indicating that exons 4 and 6 are not spliced off
in mouse brain. In addition, to confirm that exon 4 was not
spliced, another primer was used (IN-3-6 in exon 5, togetherTable 2
Comparison of the mouse and human predicted variant sequences of IlF3 and NF90
DRBP76α
M 21251-AGTAAGTGCACTTTCTG
S K C T P C
H 1671-AGTAAGTGTGCGTTTCTG
S K C A F L
DRBP76δ
M 22142-GCAGGTTTTGTATGCATT
A G F V C I
H 2560-ACAGGTTTTGTATGAATT
T G F V *
NF90 (DRBP76)
M 21692-AGTGACTTTTTCACAGA
S D F F T D
H 2120-AGTGACTTTTTCACAGAC
S D F F T D
“NVKQ region”
M 20351-ggcgtcaaatag/CAGGGACC
g v k * / Q G P
H 1149-AACGTAAAACAG/CAGGG
N V K Q / Q G
The nucleotide sequences of mouse (M) and human (H) IlF3 and NF90 predicted var
NF90 (also called DRBP76), only partial alignments can be made between mouse andwith IN-5-7). Again, as shown in Fig. 2, a single amplified
fragment of 252 bp was detected. Fragments of 74 bp that could
have been indicative of a removed exon 4 were never found.
The search for additional splicing events at the 3′ end of Ilf3
and NF90 mRNAs
Several mRNA variants of IlF3 and NF90/DRBP76 have
been described in human cell lines [3,22] due to alternativeTGTCTGCACTTGGGAAGCTGCGGCAGCATAGTCTGGGTCTCAT-21310
V C T W D A A A A *
TCTGTCTGACCTGGGAAGCAGCTGCAGTGTAGCGTCTGGGCC-1730
S V *
TTTAACCTTTTC … GTGATGAAACTGTTTCAGCACATGTGA-22231
F N L F … V M K L F Q H M *
TTTAACCTTTTA … GTGATGAAAACGATTTCACCACATCTG-2649
CTGCTACGGCTATCATGATTTTGGGGCTTCCTAGAGCGTCTAA-21751
C Y G Y H D F G A S *
TGCTACGGCTATCATGATTTTGGGTCTTCCTAGAGCGTCTAA-2179
C Y G Y H D F G S S *
GATTTTGACT-20380
I L T
GCCGATCCTGACA-1178
P I L T
iants are aligned. Deduced amino acid sequences are indicated below. Except for
human. Moreover, NF90/DRBP76 was the only variant detected in mouse brain.
Fig. 4. Intron–exon organization of the mouse Ilf 3 gene. Exons are represented by numbered black boxes. The transcription start site and the last nucleotide of exon 22
correspond to nt 43,849 and 6359, respectively, of a mouse BAC clone from chromosome 9 (GenBank Accession No. AC122525). The translation start and stop
codons and the putative polyadenylation signals are indicated. Exon 19 corresponds to the specific 3′ sequence of NF90 mRNA. Exons 20 to 22 correspond to the
specific 3′ sequence of Ilf3 mRNA. Exon 3 corresponds to an alternatively spliced sequence common to Ilf3 and NF90 mRNA. Enlargement of the exon 3 region is
represented below with underlined characters corresponding to the nucleotides found in the same position in the splice consensus motif.
627W. Viranaicken et al. / Genomics 88 (2006) 622–632transcription termination sites in exon 21 or alternative splice
acceptor sites in exon 14 or 18. We looked for the existence of
such events in mouse brain.
The 3′ untranslated region of human IlF3 was shown to be
either 600 or 3000 nt in length due to the presence of two
alternative transcription termination sites [3]. By RT-PCR using
mouse brain RNA as templates and I-5-1 and oligo(dT) as
primers (see Table 1) to explore the 3′ end of the Ilf3 mRNA,Table 3
Sizes of exons and introns and sequences at exon–intron junctions in the mouse Ilf
Exon/intron Exon size (bp) Last aa of the exon 5′ splice donor
1 229 – ggcaag (229)/(230) g
2 99 M1 aaaATG (19,927)/(19
3 39 R14 AGAAGG (20,280)/(
4 230 A90 GGCTGG (20,883)/(
5 178 T150 CTCACT (21,613)/(2
6 148 G199 CTGGAG (24,572)/(
7 92 Q230 TTCCAG (25,932)/(2
8 96 W262 GGATGG (26,420)/(
9 112 P299 TGCCAG (27,072)/(
10 98 Q332 GCGCAG (27,598)/(
11 112 T369 ACACTG (28,261)/(
12 111 K406 AGAAAG (28,457)/(
13 200 K473 GTGAAG (29,798)/(
14 168 E529 ACTGAG (30,266)/(
15 126 E571 ATGGAG (31,380)/(
16 177 K630 GCCAAG (31,722)/(
17 157 A682 ATGCTG (31,971)/(3
18 53 Y700 GCTACA (32,143/(3
19 1352 S716* −
20 366 F822 AATTCA (35,631)/(35
21 132 Q866 AACAAG (36,321)/(3
22 552 R911* −
The three RZPD cDNA sequences (Accession Nos. AA087712, BE371872, and B
AF497752, DQ104405, and DQ104406), several GenBank mouse EST sequence
AKO77560, BC047272, CD543262, CD540189, CA875190, BY687884, …), and a
(Accession No. AC122525) were used to determine the sizes of exons and introns
characters correspond to the nucleotides found in the same position in the splice coonly one fragment was amplified, corresponding to the shorter
3′ untranslated region downstream of the stop codon (Fig. 3).
We concluded that the distal transcription termination site
observed 3000 nt after the stop codon in human is not used in
mouse brain or not present in the mouse Ilf3 gene.
The junction between exon 13 and two possible acceptor
sites in exon 14 has been described in SK-MEL-28 and HeLa
human cell lines [3,22]. These two acceptor sites are 12 nt apart3 gene
3′ splice acceptor Intron size (bp)
taagt cttata (19,828)/(19,829) gatagt 19,599
,928) gtaaga acgtag (20,241)/(20,242) GCATTG 314
20,281) gtgagt ttccag (20,653)/(20,654) CGTCCC 373
20,884) gtgagt tctcag (21,435)/(21,436) GGAACA 552
1,614) gtgagt ctccag (24,424)/(24,425) ACTGTA 2811
24,573) gtaggg gaatag (25,840)/(25,841) AAACGC 1268
5,933) gtttgc ctctag (26,324)/(26,325) GCCAGA 392
26,421) gtaaga ttttag (26,960)/(26,961) CCTCTG 540
27,073) gttggg cttcag (27,500)/(27,501) ATGGTT 428
27,599) gtatag ctatag (28,149)/(28,150) CATGCT 551
28,262) gtaagg tttcag (28,346)/(28,347) TTCAAA 85
28,458) gtacga tcttag (29,598)/(29,599) AGGAGA 1141
29,799) gtaagt ccacag (30,098)/(30,099) GTGTTA 300
30,267) gtgagc aaatag (31,254)/(31,255) CAGGGA 988
31,381) gtgagt ctacag (31,545)/(31,546) GTTGAG 165
31,723) gtgagg tttcag (31,814)/(31,815) CCACAC 92
1,972) gtgagg ttgcag (32,089)/(32,090) GTGCTG 118
2,144) gtaagt ttgtag (32,581)/(32,582) GTGACT 438
gtctag(35,265)/(35,266) GTCAGT 3122
− 1332
,632) gtgagt cctcag (36,189)/(36,190) ACTACA 558
6,322) gtgggc ttgcag (36,825)/(36,826) GAGGCT 504
− −
F719583), our own RT-PCR product sequences (Accession Nos. AF497751,
s of Ilf 3/NF90 clones (Accession Nos. BB851524, CB249127, CN667318,
GenBank partial sequence of mouse chromosome 9 containing the Ilf 3 gene
shown in Fig. 3 and the sequences at the exon–intron junctions. Underlined
nsensus motif.
Fig. 5. Recombinant Ilf3 and NF90 expression in a heterologous system.
Western blot analysis of L and S isoforms of Ilf3 and NF90 present in mouse
brain or expressed in bacteria. Molecular weight markers are indicated at the left.
628 W. Viranaicken et al. / Genomics 88 (2006) 622–632and produce two isoforms containing or not the inserted
sequence NVKQ (see Table 2). Again, we did not find this event
in mouse brain (data not shown). Moreover, the use of the
upstream acceptor site should introduce a stop codon into the
mouse sequence at the fourth position (see Table 2), leading to
the formation of a truncated NF90 isoform with a predicted
length of 476 amino acids (∼52 kDa). Such a protein was never
detected in blots using our different antibodies.
Another possible way to generate an NF90 polymorphism at
the 3′ end in human cells is via the three distinct alternative
acceptor sites described for the last exon, 18, to receive the 3′ end
of the preceding exon, 17 [3]. The first classical acceptor site is at
the 5′ end of exon 18, and its usage generates NF90/DRBP76
(bringing 15 additional codons before the stop). The second
acceptor site is located upstream, in intron 17, and generates the
DRBP76α isoform in humans (8 additional codons before stop).
Finally, the third acceptor site is described downstream in exon
18 and enables the addition of only 4 amino acids before a stop
codon, generating the DRBP76δ isoform in human (Table 2). If
these events occurred in mouse, the last exon would contribute
15, 15, and 28 aa in NF90, DRBP76α, and DRBP76δ isoforms,
respectively, with no conservation of the stop positions for the
last two variants compared to the human C-termini (Table 2).
The total length and the amino acid sequences of these three
putative mouse NF90 isoforms could effectively produce a
substantial protein heterogeneity. However, by RT-PCR using
oligo(dT) as 3′ primer and oligonucleotides specific for each
putative mouse isoform as 5′ primers (N-3-1, 76α-3, and 76δ-3;
Table 1), only one sequence was systematically amplified, that
corresponding to the classical NF90/DRBP76 protein (Fig. 3).
Again, the events described in human were not found to occur in
mouse brain.
In conclusion, considering the mouse Ilf3 gene, the only
alternative splicing occurring in the brain at the 3′ end remains
that which generates Ilf3 and NF90 mRNAs. In addition,
through 5′ alternative splicing, both mRNAs can incorporate
39 nt from intron 2, leading to the translation of the two L and S
isoforms for each protein.
The Ilf3 gene map revisited
The alternative presence of these 39 nt at the beginning of the
coding sequence in Ilf3/NF90 mRNAs has revealed the
existence of a new, yet undescribed exon within intron 2 of the
Ilf3 gene. This led us to propose a new Ilf3 gene map (Fig. 4).
Table 3 indicates the sizes of exons and introns, the last amino
acid of each exon, and the sequences of the 5′ splice donor and 3′
splice acceptor sites (data were deduced from our own results,
EST clone sequencing, and analysis of numerous sequences
available in data banks). In particular, exon 1 had been described
in human but not yet in mouse [3,4]. With the existence of the
novel exon 3, the numbering of downstream exons and introns
was hence shifted (+1) compared to the previously described
gene map [3,4]. As shown in Fig. 3, the end of exon 2 carries an
ATG corresponding to the initiation codon. Exon 3 codes for aa
2–14 in L isoforms and is flanked by consensus donor/acceptor
splice sites. From this map, it appears that Ilf3 and NF90proteins share identical N-terminal 688/701 residues (688 aa for
S isoforms and 688+13 for L isoforms). Given the spliced 3′
exons, NF90 carries an additional C-terminal-specific sequence
of 15 residues (exon 19), whereas Ilf3 contains an additional C-
terminal-specific sequence of 210 residues (exons 20, 21, and 22).
The N-terminal 13-aa sequence from exon 3
Full-length Ilf3 and NF90 nt sequences were built from three
EST and PCR products as well. For each protein, constructs with
or without the 39-nt sequence (L or S isoforms, respectively) were
produced and expressed inEscherichia coli.Bacterially expressed
L and S Ilf3 and NF90 isoforms were subjected to resolving
SDS–PAGE, in parallel with mouse brain extracts (Fig. 5), and
the proteins were detected by Western blotting using specific
antibodies [2]. Fig. 5 shows that the alternative presence of this
13-aa sequence is sufficient to explain the heterogeneity in the
apparent molecular weight of Ilf3 and NF90. When the
migration of brain and bacterially expressed Ilf3 and NF90 was
examined closer, bacterially expressed proteins migrated
slightly faster than the corresponding brain proteins.
To see whether this difference is due to posttranslational
modifications undergone by both proteins in brain tissues,
modifications that bacteria are unable to make, cDNA
constructs were transcribed and translated in vitro in rabbit
reticulocyte or E. coli lysates. The Ilf3 and NF90 isoforms
synthesized in vitro under these conditions were fractionated by
SDS–PAGE in parallel with bacterially expressed Ilf3 and
NF90 as well as with proteins from mouse brain and mouse P19
and human HeLa, HepG2, and HEK293 cell lines. We observed
that proteins synthesized in vitro and bacterially expressed
proteins migrated identically and faster than endogenous
cellular proteins (data not shown). Since eukaryotic posttransla-
tional modifications are usually not performed when proteins
are produced in bacteria or synthesized in vitro in rabbit
reticulocyte lysates, this observation reinforces the idea that Ilf3
and NF90 are substrates for posttranslational modifications in
eukaryotic cells.
The sequence of the N-terminal 13-aa alternative segment is
specific to Ilf3 and NF90. When probed with the (M)
ALYHHHFITRRRR sequence, only these two proteins were
found in data banks.
629W. Viranaicken et al. / Genomics 88 (2006) 622–632Discussion
Previous work had shown that two mRNAs are produced by
alternative splicing in the 3′ region of the Ilf3 pre-mRNA,
leading to the synthesis of Ilf3 and NF90 proteins. Here, we
report the occurrence in the mouse brain of another alternative
splicing event, in the 5′ region, involving both Ilf3 and NF90
mRNAs. The spliced 39-nt sequence corresponds to a small
exon, not described so far, located just downstream of the
translation initiation codon in the mature mRNA. It codes for a
13-aa sequence specific for Ilf3 and NF90 and containing a
stretch of basic residues.
Since IlF3 and NF90 were shown to be ubiquitously
expressed in several mouse tissues and human cell lines (data
not shown), we searched for the presence of sequences cor-
responding to this novel exon in HeLa cell mRNA by RT-PCR
assay. As expected from data bank analysis, we found this
alternatively spliced exon in human mRNA (data not shown).
Moreover, IlF3 and NF90 from HeLa cell extracts separated by
2-D electrophoresis exhibited the same heterogeneous patterns
as those observed in mouse brain extracts (data not shown),
indicating that human and mouse IlF3 and NF90 share similar
polymorphisms.
We also investigated the occurrence in mouse brain of
other alternative splicing events previously reported in the
mouse EST data bank and in human [3,22]. However, by RT-
PCR using different specific primers, the expected products
were never detected in mouse brain.
Concerning the possible splicing of exons 4 and 6, we
showed by RT-PCR experiments that these events do not occur
at all in mouse brain (see Fig. 2). Moreover, if such events had
occurred, the translation of the corresponding spliced mRNAs
lacking either exon 4 or exon 6 sequences would have led to the
synthesis of truncated forms of Ilf3/NF90 proteins containing
only the first 92 or 238 amino acid residues, respectively.
Indeed, the resulting shift in the open reading frame would
introduce a stop codon at the beginning of exon 5 or 8,
respectively. Sequences lacking both exons would give
shortened proteins (92 aa), as for sequences devoid of exon 4
and for the same reason. Such truncated forms of the proteins
containing only a short part of the common region of Ilf3 and
NF90 were never observed by immunodetection following
separation of total mouse brain extracts by SDS–PAGE. If these
shortened proteins were present, they would have been detected
by our antibody Ab78 that recognizes an N-terminal sequence
of Ilf3/NF90 [2].
It was also previously described that the use of an alternative
3′ acceptor splice site generated human IlF3/NF90 mRNA
containing the sequence coding an NVKQ motif [3]. Analysis
of cDNA or protein sequences available in data banks showed,
however, that this motif is found in only very few human and
macaque sequences. To detect the presence in mouse brain of
this and other variants (DRBP76α and DRBP76δ) described in
human cell lines [3], we used different pairs of primers in
nested RT-PCR assays. No signal was ever observed after PCR
amplification. Furthermore, as no additional signal was
obtained after Western blotting using polyclonal antibodiesrecognizing peptides common to all predicted isoforms, we
finally concluded that these variants are not expressed in mouse
brain.
Altogether, our experiments indicate that mouse brain Ilf3/
NF90 mRNAs do not undergo the following posttranscriptional
modifications either reported in human cell lines or deduced
from mouse data bank sequences: lengthening of exon 4,
alternative splicing of exon 4 and/or exon 6, and the various
events at the 3′ end. The primary transcription products of the
mouse Ilf3 gene are subject to one alternative splicing in its 3′
region that gives rise to Ilf3 and NF90 mRNAs. In addition, a
second alternative splicing event can occur in the 5′ region,
providing each mRNAwith the possibility of retaining a unique
39-nt sequence that codes for an N-terminal attachable 13-aa
stretch (aa 2–14).
Combining these experimental results with genomic, cDNA,
and EST sequences available in data banks, we have proposed
for the first time a complete map of the mouse Ilf3 gene with an
additional exon. This gene contains 22 exons, 17 of which
(exons 1, 2, and 4–18) are common to all Ilf3 and NF90
transcripts. One alternatively spliced exon, located in the 5′
region (new exon 3), is retained only in the L Ilf3 and NF90
isoforms. In the 3′ gene region, exon 19 is specific for NF90
transcripts, whereas the last 3 exons (20–22) are specific to Ilf3
transcripts. Thus, alternative splicing of Ilf3 gene transcripts
leads to the synthesis of four different mRNAs, two coding for L
and S Ilf3 and two for L and S NF90.
From chromosome sequence analysis, no TATA and CAAT
boxes were found upstream of the Ilf3 gene transcription start
site. This genic organization does not correspond to those
generally exhibited by RNA polymerase II-transcribed genes.
One consequence of the absence of consensus boxes is that the
5′ ends of the RNAs are heterogeneous, transcription starting at
nt +1, +2, or +3. Alignment of available Ilf3/NF90 5′ cDNA
sequences confirms this predicted heterogeneity.
Analysis of cDNA and EST showed that Ilf3 and NF90
sequences are found in many species from sea urchin to human
with amino acid identities varying from 98.4 to 55.4%.
Homologous sequences were not found in insects, plants, or
yeast. Exon 3 was detected only in mouse, rat, and human IlF3
and NF90 sequences and not in other mammals (chimpanzee,
orangutan, dog, and cow), vertebrates (chicken, Xenopus), fish
(zebrafish, tetraodon), or invertebrates (sea urchin).
The expression levels of the IlF3 and NF90 isoforms are
not identical. In all mouse tissues or cell lines and in the
human cell lines examined so far, Western blot analyses
showed that, in each case, IlF3 is always two- to threefold
more abundant than NF90 (data not shown). Since IlF3 and
NF90 mRNAs are generated from the same premessenger
RNA, this suggests that alternative splicing does not proceed
at random, unless the half-lives of IlF3 and NF90 are very
different. This latter hypothesis can be easily ruled out,
however, since values measured in HepG2 cells were reported
to be quite similar [23]. It thus appears that the alternative
splicing event producing IlF3 mRNA is more favored than
that producing NF90 mRNA. On the other hand, concerning
the alternative splicing of exon 3, we observed that the relative
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cell line or tissue to another (data not shown). The differences
between the L and the S IlF3/NF90 isoform ratios might be
related to the specific cellular functions each protein has to
assume.
In this paper, we have demonstrated the posttranscriptional
origin of a part of the Ilf3/NF90 protein heterogeneity. Analysis
of its consequence in the subcellular localization of Ilf3/NF90
and/or in the regulation of their functions is currently in progress.
However, as judged by the extent of the Ilf3 and NF90
polymorphism observed after resolving 2-D PAGE [2], it is
obvious that this heterogeneity cannot be generated solely by
alternative splicing events. It is likely that posttranslational
modifications such as, at least, arginine methylation and
phosphorylation are involved, increasing the possibility of
modulating the cellular functions of the various Ilf3 and NF90
isoforms.Experimental procedures
Total RNA purification
Fifteen-day-old embryonic or adult mouse brains were resuspended in
extraction buffer (4 mol ·L−1 guanidinium thiocyanate, 25 mmol ·L−1 sodium
citrate, pH 7.0, 0.5% w/v Sarkosyl, 100 mmol L−1 2-β-mercaptoethanol) and
then total RNAwas isolated by phenol extraction [24] and solubilized in RNase-
free H2O.
Oligodeoxynucleotides
Oligodeoxynucleotides were purchased from MWG (Courtaboeuf, France).
Numbering of Ilf 3 primer nucleotides was done according to the mouse Ilf 3
sequence published previously (GenBank Accession No. AF098967; Bethesda,
MD, USA [11]). That of NF90-specific primers was done according to the
mouse NF90 sequence deduced from the complete genomic sequence (GenBank
Accession No. AF506968). Oligodeoxynucleotides used for reverse transcrip-
tion, PCR, and cloning are listed in Table 1.
Reverse transcription, PCR, and nested PCR
For reverse transcription, the first cDNA strand was synthesized with AMV
reverse transcriptase (Roche, Indianapolis, IN, USA) using either (AGC)dT or
IN-3-5 oligodeoxynucleotide as primer. All PCR was carried out with Herculase
Pfu enzyme (Stratagene, La Jolla, CA, USA) for 30 cycles in a Genius PCR
system (Techne, Cambridge, UK). For PCR analysis of the common 5′ region of
Ilf 3/NF90, the template used was cDNA generated by reverse transcription with
primer IN-3-5. For the other PCR experiments, the templates used were cDNA
generated by reverse transcription with (AGC)dT oligodeoxynucleotide as
primer.
To analyze the 5′ region of Ilf 3 and NF90 cDNA, the first PCR was carried
out using IN-5-1 and IN-3-5, and the second nested PCR was performed using
IN-5-2 and IN-3-7 (see Table 1 and Fig. 1). To study specifically the Ilf 3 or
NF90 5′ region, the same steps were preceded by a preliminary PCR using IN-5-
1 and I-3-1 or IN-5-1 and N-3-1, respectively.
The presence of a longer exon 3 containing 15 additional nucleotides at its 5′
end was investigated as above. To reduce the size of the amplified fragments and
to enhance the resolution of the electrophoretic separation, the second nested
PCR was also carried out with IN-5-3 and IN-3-7.
The presence of transcripts devoid of exon 4 and/or exon 6 was studied by
nested PCR with IN-5-2 and IN-3-1 for the first PCR. For the second PCR, we
used IN-5-7 and IN-3-4, to analyze the putative alternative splicing of exon 4
and/or exon 6, or IN-5-7 and IN-3-6, to study specifically the putative alternative
splicing of exon 4 (see Table 1 and Fig. 2).The presence of two putative 3′ acceptor sites in intron 13was investigated by
two nested PCR, one with IN-5-8 and (AGC)dTand the other with IN-5-9/IN-3-2
or IN-5-10/IN-3-2. The 3′ region of Ilf 3 transcripts was studied by two
successive PCR using IN-5-8/(AGC)dT and I-5-1/(AGC)dT. The 3′ region of
NF90 transcripts was investigated by two PCR, one using IN-5-8/(AGC)dT and
three different nested PCR with IN-5-8/N-3-1, IN-5-8/76α-3, or IN-5-8/76δ-3.
Finally, the 3′ region of NF90 transcripts was entirely determined by sequencing
the fragments resulting from two successive PCR with IN-5-8/(AGC)dT and
N-5-1/(AGC)dT.
PCR products were fractionated in 1, 1.5, or 2.0% (w/v) agarose gels and
stained with ethidium bromide. When mentioned, PCR products were heat-
denatured 10 min at 95°C and slowly renatured by progressively decreasing the
temperature by 1°C every 3 min [21]. In some cases, cDNA fragments were
electroeluted from gels and cloned in pSK(+) plasmid at the EcoRV unique
restriction site. After amplification of the constructs in E. coli strain XL1 Blue
(Stratagene), DNA plasmids were purified using the QIAfilter Plasmid Midi Kit
(Qiagen, Mayence, Germany) and sequenced (Genome Express, Meylan,
France).Probe labeling and Southern blot
Ilf 3 cDNA probe was labeled by random priming with [α-32P]dCTP using
Klenow enzyme (Roche). Oligodeoxynucleotide probes were 5′-labeled by
phosphorylation with [γ-32P]ATP using T4 polynucleotide kinase (Roche). PCR
products were fractionated in a 1.5% (w/v) agarose gel and then transferred by
capillarity [25] onto a Hybond N+ membrane (Amersham Biosciences, Little
Chalfont, UK) using the alkaline method [26]. Membranes were prehybridized
at 55°C for 2 h in Church buffer (1 mmol · L−1 EDTA, 0.5 mol ·L−1 NaHPO4,
pH 7.2, 10% w/v BSA, 7% w/v sodium dodecyl sulfate) [27] and then
hybridized for 18 h in the same fresh buffer supplemented with 0.25% (v/v) 32P-
labeled probe. Membranes were washed three times for 45 min at room
temperature, 45°C, and 60°C with 2× SSC (1× SSC is 0.15 mol ·L−1 NaCl,
15 mmol ·L−1 sodium citrate) and then autoradiographed (Hyperfilm MP,
Amersham Biosciences).Construction of the cDNA containing Ilf3 or NF90 coding
sequences
Three RZPD (Berlin, Germany) clones (GenBank Accession Nos.
AA087712, BE371872, and BF719583), selected from the mouse EST
database, overlapped the entire coding sequence of the Ilf 3 gene, except for
39 nt in the 5′ region able to be alternatively spliced during the premessenger
RNA maturation (Fig. 1). First, the cDNA of the BE371872 clone was
digested with XcmI and SacI, and the cDNA of the BF719583 clone was
digested with SacI and BamHI. To obtain the 5′ region of the final constructs,
we carried out a supplementary PCR step, using the cDNA of the AA087712
clone as template, to introduce a restriction site for NotI in the two forms of
Ilf 3 and, for only the long one, the 39 nt missing in the RZPD clone. To
construct the cDNA of the small form, one PCR was done using IN-3-2 and
IN-5-6 as primers. To construct the cDNA of the long form, two successive
PCR were done using IN-3-2 as 3′ primer and IN-5-5, and then IN-5-4, as 5′
primer. The final PCR products were double-digested with NotI and XcmI,
isolated in agarose gel, and electroeluted. The three cDNA fragments were
finally subjected to a DNA ligase in the presence of pSK(+) cDNA linearized
by the action of NotI and BamHI.
The construction of NF90 clones was performed using plasmids containing
the Ilf 3 sequence as template. Two successive PCR were carried out using IN-5-
8 as 5′ primer and N-3-3, and then N-3-2, as 3′ primer. The final PCR products
were double-digested with NsiI and BamHI, subjected to a DNA ligase in the
presence of pSK(+) cDNA containing either the short or the long sequence of
Ilf 3, and linearized by the action of NsiI and BamHI.
To construct the prokaryote expression vectors, Ilf 3 and NF90 long and
short sequences were excised from pSK(+) by double digestion with NotI and
BamHI, isolated in 0.7% (w/v) agarose gel, electroeluted, and finally subcloned
in pET21b (Novagen, Merck Biosciences, Darmstadt, Germany) previously
linearized with the same restriction enzymes.
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ligation in E. coli strain XL1 Blue (Stratagene) and then DNA plasmids were
purified using the QIAfilter Plasmid Midi Kit (Qiagen).
Sequencing and GenBank accession numbers
All PCR products were controlled by sequencing of both DNA strands
(Genome Express). Some of the sequence data obtained appear in the GenBank
nucleotide sequence database under Accession Nos. AF497751 and AF497752,
for the long and small Ilf 3 cDNA, and DQ104405 and DQ104406, for the long
and small NF90 cDNA.
Ilf3 and NF90 bacterial expression
Purified plasmids were introduced into the E. coli strain Epicurian Coli
BL21-CodonPlus (DE3)-RIL (Stratagene). When the culture OD600 reached 0.6,
bacteria were maintained for 30 min at 4°C before the induction of protein
expression by addition of isopropyl-β-D-galactopyranoside (1 mmol ·L−1) in the
LB culture medium. After 4 h of induction at room temperature, bacteria were
recovered by centrifugation for 30 min at 3000 g at 4°C, and the pellet was
resuspended in extraction buffer (8.1 mmol ·L−1 Na2HPO4, 1.8 mmol ·L
−1
KH2PO4, 137 mmol ·L
−1 NaCl, 2.7 mmol · L−1 KCl, 5% v/v glycerol, 1 mmol ·
L−1 ethylenediaminetetraacetic acid, 1 mmol ·L−1 ethylene glycol-bis(β-
aminoethyl ether)-N,N,N′,N′-tetraacetic acid, 1 mmol ·L−1 dithiothreitol, 0.5%
v/v Triton X-100, protease inhibitors (10 μg ml−1 aprotinin, 10 μg ml−1
leupeptin, 1 mmol L−1 4-(2-aminoethyl) benzene sulfonyl fluoride), with 1 ml of
buffer for 25 ml of culture medium. After pellet recovery, the extraction buffer
was supplemented with 1 mg ml−1 lysozyme and 75 μg ml−1 RNase-free DNase
I. After 30 min at 4°C, the solution was homogenized by sonication and
insoluble material was recovered by centrifugation for 20 min at 16,000 g at
4°C.
Protein extraction
Soluble protein fractions were prepared from mouse brain [2]. Protein
concentrations were determined using the bicinchoninic acid method (Micro
BCA Protein Assay Reagent Kit, Pierce, Rockford, IL, USA) using bovine
serum albumin as standard.
SDS–PAGE and Western blot
SDS–PAGE was performed according to Laemmli [28] with minor
modifications to enhance the separation of Ilf 3 and NF90 isoforms (separating
gel at pH 8.6 and acrylamide/bisacrylamide at 8%/0.1075%). Electrotransfer of
proteins onto nitrocellulose (Hybond C; Amersham Biosciences) was performed
essentially as described [29]. After membrane saturation in TBS-T
(20 mmol ·L−1 Tris, pH 7.5, 136.8 mmol ·L−1 NaCl, 0.1% v/v Tween 20)
containing 2% (w/v) low-fat milk, Ab78 serum [2] was incubated overnight in
TBS-T at room temperature and revealed with peroxidase-linked secondary
antibodies (Sigma–Aldrich) by the chemiluminescence method.
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